glp-1 and gallbladder disease Glucagon-like peptide-1 receptor agonist use may up risk for gallbladder, biliary diseases Why GLP-1 Agonists Like Ozempic

In the head-to-head SURPASS-2 trial (NEJM 2021), tirzepatide 15 mg beat semaglutide 1 mg on HbA1c (2.30% vs 1.86%) and weight loss (11.2 kg vs 5.7 kg)

Also, many trials had short follow-up mostly 1 or 2 years which is not sufficient to detect long-latency effects on cancer risk or prevention, he added

is studying the active ingredient of its diabetes treatment, Mounjaro, and its anti-obesity cousin, Zepbound, with children as young as 6

Il gre aussi une dtoxification hpatique

Additionally, chronic colds, illnesses, toxin exposure (i.e

136 Inducing ferroptosis may be a promising therapeutic approach for targeting leukemia cells